MYL

Mylan Inc. News Headlines

$53.925
*  
1.555
2.97%
Get MYL Alerts
*Delayed - data as of Oct. 31, 2014 10:06 ET  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Is Mylan's Lively Third Quarter the Start of Something Special?
10/30/2014 9:51:32 PM - Motley Fool


Pfizer's Trumenba Gains Accelerated Approval in the U.S. - Analyst Blog
10/30/2014 6:04:00 PM - Zacks.com


Dr. Reddy's (RDY) Q2 Earnings Fall, Revenues Up Y/Y - Analyst Blog
10/30/2014 5:20:00 PM - Zacks.com


Mylan (MYL) Stock Higher In After-Hours Trading Following Third Quarter Earnings Results
10/30/2014 5:09:00 PM - TheStreet


Mylan Q3 Profit Tops Estimates; Lifts 2014 Adj. EPS Guidance - Quick Facts
10/30/2014 4:58:00 PM - RTT News


Mylan Q3 14 Earnings Conference Call At 4:30 PM ET
10/30/2014 3:00:00 PM - RTT News


After-Hours Earnings Report for October 30, 2014 : SBUX, PSA, CCI, LNKD, MYL, RSG, ESS, FLT, EMN, NEM, FLR, MHK
10/30/2014 2:00:03 PM - NASDAQ.com News


The Medicines Co.'s Angiomax Gets Favorable Court Ruling - Analyst Blog
10/28/2014 6:31:00 PM - Zacks.com


3 Generics Stocks to Buy Now - Analyst Blog
10/28/2014 10:28:00 AM - Zacks.com


AEZS To Watch Out, RCPT Surges In Afterhours, CEMI Focuses On Ebola, PTIE Hurt
10/28/2014 12:39:00 AM - RTT News


The Medicines Co.'s Q3 Earnings Fall Y/Y, Guidance Lowered - Analyst Blog
10/27/2014 1:00:00 PM - Zacks.com


The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4% - Tale of the Tape
10/27/2014 9:21:46 AM - Zacks.com


Pfizer Approves $11 Bln Share Buyback, Dividend; Wins Sutent Patent Case
10/23/2014 9:39:00 PM - RTT News


Pfizer Wins SUTENT Patent Case In Delaware District Court - Quick Facts
10/23/2014 8:09:00 AM - RTT News


Abbott Laboratories' EPS Up 12% On Emerging Market Strength
10/22/2014 11:50:00 AM - Seeking Alpha


Mylan And Abbott Labs Amend Agreement On Branded Generics Business
10/22/2014 10:36:00 AM - RTT News


Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated - Analyst Blog
10/22/2014 10:28:00 AM - Zacks.com


Supernus' Trokendi XR Faces Generic Threat from Zydus - Analyst Blog
10/15/2014 6:45:00 PM - Zacks.com


Mallinckrodt Gives FY15 Guidance Post Questcor Acquisition - Analyst Blog
10/15/2014 5:10:00 PM - Zacks.com


Why Teva Pharmaceutical (TEVA) Stock Is Falling Today
10/15/2014 2:53:00 PM - TheStreet


AxoGen (AXGN) Shows Strength: Stock Up 15.4% in Session - Tale of the Tape
10/13/2014 9:39:00 AM - Zacks.com


Impax Up, Set to Buy Tower Holdings & Lineage Therapeutics - Analyst Blog
10/10/2014 5:05:00 PM - Zacks.com


Impax Laboratories Inc. (IPXL) in Focus: Stock Rises 11.8% - Tale of the Tape
10/10/2014 9:32:00 AM - Zacks.com


Teva Starts Rolling Submission of its Pain Drug CEP-33237 - Analyst Blog
10/9/2014 4:45:00 PM - Zacks.com


Ligand Provides Better-than-Expected Q3 Earnings Guidance - Analyst Blog
10/9/2014 4:10:00 PM - Zacks.com